United States
Premiumsupplier
Satralizumab Linker CAS NO.2616704-22-2
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- 6,12,15,18,21,24,27,30,33-Nonaoxa-3,9-diazapentatriacontanamide, 2-(4-aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]...
- (2S)-2-(4-Aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-N-[4-(hydroxymethyl)phenyl]-4,8-dioxo-6,12,15,18,21,24,27,3...
Quick Details
- ProName: Satralizumab Linker
- CasNo: 2616704-22-2
- Molecular Formula: C50H79N9O16
- Application: For research use only.
- Purity: 95%
- LimitNum: 0
Superiority
We provide customized and high-quality Satralizumab Linker product for your project.
Details
Satralizumab Linker is a key compound utilized in the biomedical industry to develop targeted drug therapies. It plays a vital role in conjugating satralizumab, an antibody used for treating neuromyelitis optica spectrum disorder (NMOSD), with a specific
